Form 6-K BioLineRx Ltd. For: Sep 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. GNK
5. USO
6. ARGX
7. AZN
8. SPCX
9. UNG
10. FNGR

Go back to Form 6-K BioLineRx Ltd. For: Sep 08

Roth Positive on BioLineRx (BLRX) Amid Latest BL-8040 Phase 2a Data in r/r AML

September 8, 2016 9:59 AM EDT

Roth Capital affirms its Buy rating and $7 price target on BioLineRx Ltd. (Nasdaq: BLRX) after the company announced the presentation of successful final results of BL-8040's Phase 2a clinical trial in relapsed or refractory acute myeloid leukemia (r/r AML).

Analyst Joseph Pantginis commented today, The final r/r AML data continue to point to a bright path forward... More